HIV, Diagnosis, Treatment and Current Research
- Human Immunodeficiency Virus (HIV) is an enveloped virus, belonging to the viral family Retroviridae. It is a highly evolved virus which has grasped the attention of all researchers with its special features like morphology, genetics and also by its emerging nature. The special feature of all retro viruses is the presence of an enzyme called Reverse transcriptase which plays major role in reverse transcription process. HIV enters the host body, damages immune system and will cause life-threatening opportunistic infections finally leads to AIDS (Acquired Immunodeficiency Syndrome).
- Diagnosis of Human Immunodeficiency Virus can be performed by various bio-chemical techniques. Body fluids like saliva, urine or serum of suspected individuals should be collected for the detection of RNA, antibodies or antigens. Diagnoses through antibody detection tests are specially designed biochemical techniques which are extremely accurate and inexpensive. ELISA and Western blot techniques are well-known antibody detection tests for the diagnosis of HIV.
- Antiretroviral treatment are medications that treat HIV. The drugs do not kill or cure the virus. However, when taken in combination they can prevent the growth of the virus. When the virus is slowed down, so is HIV disease. Antiretroviral drugs are referred to as ARV. Combination ARV therapy (cART) is referred to as highly active ART (HAART). Each type, or “class”, of ARV drugs attacks HIV in a different way. The first class of anti-HIV drugs was the nucleoside reverse transcriptase inhibitors (also called NRTIs or “nukes”.) These drugs block step 4, where the HIV genetic material is used to create DNA from RNA.
- Current Research deals with morphology and genetic alterations of HIV with main focus on infection, transmission, replication, reverse transcription, diagnosis, vaccine research, immunological reactions, prevention and treatment techniques, etc.
- Rapid Detection of Infectious Agents
- Viral Vaccines
- Bacterial Viral Interactions
- Fungal Infections
- Bacterial Infections
- Immunology of Infections
- Parasitic infections
- HIV/AIDS and Retroviral Diseases
- STDs/STIs and Infertility
- Dermatological Infectious Diseases
- Respiratory Infectious Diseases
- Pediatric Infectious Diseases
- Urinary tract infections
- Vector-borne Diseases
- Diagnosis of infectious diseases
- Non communicable Infectious Diseases
- STD & HIV Infection
- Viral Infections of Humans
Related Conference of HIV, Diagnosis, Treatment and Current Research
August 13-14, 2024
10th International Congress on Trauma, Critical Care and Emergency Medicine
Amsterdam, Netherlands
September 26-27, 2024
19th International Conference on Virology, Emerging Diseases & vaccines
Montreal, Canada
October 24-25, 2024
9th International Conference on Molecular Medicine and Diagnostics
Zurich, Switzerland
November 25-26, 2024
8th International Conference on Microbiome, Probiotics & Gut Nutrition
London, UK
December 02-03, 2024
7th International Conference on Antimicrobial and Antibacterial Agents
Prague, Czech Republic
December 02-03, 2024
7th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Prague, Czech Republic
HIV, Diagnosis, Treatment and Current Research Conference Speakers
Recommended Sessions
- Antiviral Drugs
- Clinical virology
- Deadliest Virus
- Diagnosis of Infectious Diseases
- Diagnostic virology
- Emerging Infectious Diseases
- Emerging Viral Diseases
- Epidemiology Of Viral Diseases
- Food virology
- Gastrointestinal Infections
- Gastrointestinal infections
- Hepatitis B Virus Infection
- Herpes Simplex Virus
- HIV, Diagnosis, Treatment and Current Research
- Infection Control
- Influenza virus
- Medical Virology
- Molecular virology
- Neonatal Infections
- Neuro virology
- Nipah virus (NiV)
- Plant Virology
- Respiratory Viral Infections
- Skin infection
- Structural Virology
- Urinary Tract Infection (UTI)
- Veterinary Virology
- Viral Diseases
- Viral Gene Therapy
- Viral Hepatitis
- Viral Immunology
- Viral infection and their control
- Viral Oncology
- Viral Vaccine
Related Journals
Are you interested in
- 16S sequencing & Analysis - Microbiome 2024 (UK)
- Agriculture Microbiology - Beneficial Microbes 2024 (Ireland)
- Animals in a bacterial world, a new imperative for the life sciences - Microbiome 2024 (UK)
- Antimicrobial Use in Veterinary Medicine - Antimicrobial Congress 2024 (Czech Republic)
- Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Antiviral Therapies and Drug Development - Antimicrobial Congress 2024 (Czech Republic)
- Arbuscular Mycorrhizal Fungi [AMF] - Microbiome 2024 (UK)
- Beneficial Microbes in the environment - Beneficial Microbes 2024 (Ireland)
- Benefits Of Bio stimulants - Microbiome 2024 (UK)
- Bioinformatics for Microbiome - Microbiome 2024 (UK)
- Biological Need of Trauma - TRAUMA 2024 (Netherlands)
- Biostimulants and Biocontrol strategies - Microbiome 2024 (UK)
- Blunt Trauma - TRAUMA 2024 (Netherlands)
- Clinical and Neuro Virology - Virology-2024 (Canada)
- Combination Therapy for Antimicrobial Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Corona Virus - Virology-2024 (Canada)
- Critical Care in Trauma - TRAUMA 2024 (Netherlands)
- Delirium in Critical Care - TRAUMA 2024 (Netherlands)
- Drug-Resistant Bacteria: Challenges and Solutions - Antimicrobial Congress 2024 (Czech Republic)
- Ecology and Evolution of Microbe-Host Interactions - Beneficial Microbes 2024 (Ireland)
- Elderly Trauma and Critical Care - TRAUMA 2024 (Netherlands)
- Engineering Beneficial Microbes - Beneficial Microbes 2024 (Ireland)
- Evolution in Emergency Medicine Practices - TRAUMA 2024 (Netherlands)
- General Virology - Virology-2024 (Canada)
- Gut Micro biota - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- HIV/AIDS and Sexually Transmitted Infections - Virology-2024 (Canada)
- Horticulture Hydroponics - Microbiome 2024 (UK)
- Host-Microbe Biology (HMB) - Microbiome 2024 (UK)
- Human Micro biota - Microbiome 2024 (UK)
- Immunization and Immunotherapeutics - Virology-2024 (Canada)
- Immunobiotics - Beneficial Microbes 2024 (Ireland)
- Influenza and other Respiratory Diseases - Virology-2024 (Canada)
- Intensive Care in Trauma - TRAUMA 2024 (Netherlands)
- Interplay between diet, gut micro biota, epigenetic events, and colorectal cancer - Microbiome 2024 (UK)
- Marine Microbiology - Beneficial Microbes 2024 (Ireland)
- Mechanisms of Antibiotic Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Micro biota in early life shapes the immune system - Microbiome 2024 (UK)
- Microbial Infections - Virology-2024 (Canada)
- Microbiome - Beneficial Microbes 2024 (Ireland)
- Microbiome - Microbiome 2024 (UK)
- Microbiome as a human organ - Microbiome 2024 (UK)
- Microbiome: Science comes to life - Microbiome 2024 (UK)
- Modulation of Micro biota - Microbiome 2024 (UK)
- Nanotechnology in Antimicrobial Drug Delivery - Antimicrobial Congress 2024 (Czech Republic)
- New and Endogenous Retroviruses - Virology-2024 (Canada)
- New Technology in Trauma - TRAUMA 2024 (Netherlands)
- Novel Antibiotics and Antimicrobial Agents - Antimicrobial Congress 2024 (Czech Republic)
- Novel Antiviral Therapies - Virology-2024 (Canada)
- Novel Vaccine Delivery Methods - Virology-2024 (Canada)
- Obstetric Trauma - TRAUMA 2024 (Netherlands)
- Paediatric Trauma - TRAUMA 2024 (Netherlands)
- Pathogenic Microbes in Immunology and Microbiology - Beneficial Microbes 2024 (Ireland)
- Pathogenic Microbes in Medicine and Dentistry - Beneficial Microbes 2024 (Ireland)
- Pediatric Microbiome [Vaginal Delivery Versus C-Section] - Microbiome 2024 (UK)
- Pharmacogenomics - Microbiome 2024 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Plant Beneficial Microbes - Microbiome 2024 (UK)
- Plant Conditioners [Biostimulants] - Microbiome 2024 (UK)
- Prebiotics and Probiotics - Microbiome 2024 (UK)
- Probiotics & Prebiotics - Beneficial Microbes 2024 (Ireland)
- Psychological Trauma - TRAUMA 2024 (Netherlands)
- Role of microbial communities in the pathogenesis of periodontal diseases and caries (Oral Microbiome) - Microbiome 2024 (UK)
- Signaling in the phytoMicrobiome - Microbiome 2024 (UK)
- Skincare products with probiotics worth the hype - Microbiome 2024 (UK)
- Soil biological management - Beneficial Microbes 2024 (Ireland)
- Strategies for Fungal Infections - Antimicrobial Congress 2024 (Czech Republic)
- Structural and Molecular virology - Virology-2024 (Canada)
- The Dynamic Microbiome - Microbiome 2024 (UK)
- The globalization of cannabis cultivation- A Growing Challenge - Microbiome 2024 (UK)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2024 (UK)
- The role of the Microbiome in cancer development and therapy - Microbiome 2024 (UK)
- The Skin Microbiome - Microbiome 2024 (UK)
- Transmission of Viruses - Virology-2024 (Canada)
- Transplant-Associated Viral Infections - Virology-2024 (Canada)
- Trauma & Critical Care Nursing - TRAUMA 2024 (Netherlands)
- Trauma Emergency Medicine - TRAUMA 2024 (Netherlands)
- Trauma in Nursing & Midwifery - TRAUMA 2024 (Netherlands)
- Trauma Therapy - TRAUMA 2024 (Netherlands)
- Trauma-An International Perspective - TRAUMA 2024 (Netherlands)
- Trauma-Mass Casualties Incidents - TRAUMA 2024 (Netherlands)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2024 (Canada)
- Vaccines and Immunotherapies - Antimicrobial Congress 2024 (Czech Republic)
- Vaccines and the Microbiome - Virology-2024 (Canada)
- Veterinary virology - Virology-2024 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2024 (Canada)
- Viral Immunology and Immunopathology - Virology-2024 (Canada)
- Viral Oncology - Virology-2024 (Canada)
- Viral Pathogenesis - Virology-2024 (Canada)